The Food and Drug Administration has approved the GORE VIABAHNN Endoprostheis for use in patients with femoral artery lesions. Gore Medical touts the flexibility and “stamina” of the the stent as its main advantages:
The road through an occluded SFA is full of twists and turns. A successful journey demands a strong yet extremely flexible stent-graft capable of adapting to the tortuous challenges and relentless forces of the SFA.
The GORE VIABAHN® Endoprosthesis stent-graft offering from W. L. Gore & Associates, a leader in interventional products, redefines endoprosthesis performance by providing a combined ePTFE/Nitinol self-expanding stent-graft preloaded on a catheter-based delivery system. The ePTFE /Nitinol self-expanding stent-graft has the stamina to perform in territory where other devices should not venture. In fact, the GORE VIABAHN® Endoprosthesis is the only device qualified to open the road and keep it open.
The product page…